A New Market Week, President Trump’s COVID-19 Recovery Status, Pharma M&A And The Virus’ Impact On The Movie Theater Industry
Carl Quintanilla, Jim Cramer and David Faber focused on stocks' positive start to a new week of trading, Wall Street hoping that President Trump is recovering from COVID-19 and that the stimulus talks will result in Congress passing a relief bill. They also discussed the CEO of Regeneron telling CNBC that he hopes the company's antibody cocktail will help President Trump recover from COVID-19. The virus continuing to impact the movie theater industry as Regal Cinemas decides to suspend operations at its U.S. theaters. M&A in the spotlight as Bristol-Myers agrees to acquire drug maker MyoKardia in a $13-billion deal.
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Carl Quintanilla, Jim Cramer and David Faber focused on stocks' positive start to a new week of trading, Wall Street hoping that President Trump is recovering from COVID-19 and that the stimulus talks will result in Congress passing a relief bill.
They also discussed the CEO of Regeneron telling CNBC that he hopes the company's antibody cocktail will help President Trump recover from COVID-19. The virus continuing to impact the movie theater industry as Regal Cinemas decides to suspend operations at its U.S. theaters. M&A in the spotlight as Bristol-Myers agrees to acquire drug maker MyoKardia in a $13-billion deal.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.